194 related articles for article (PubMed ID: 12084876)
1. Clinicopathological features of genetically confirmed Danon disease.
Sugie K; Yamamoto A; Murayama K; Oh SJ; Takahashi M; Mora M; Riggs JE; Colomer J; Iturriaga C; Meloni A; Lamperti C; Saitoh S; Byrne E; DiMauro S; Nonaka I; Hirano M; Nishino I
Neurology; 2002 Jun; 58(12):1773-8. PubMed ID: 12084876
[TBL] [Abstract][Full Text] [Related]
2. Disease model: LAMP-2 enlightens Danon disease.
Saftig P; Tanaka Y; Lüllmann-Rauch R; von Figura K
Trends Mol Med; 2001 Jan; 7(1):37-9. PubMed ID: 11427988
[TBL] [Abstract][Full Text] [Related]
3. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).
Nishino I; Fu J; Tanji K; Yamada T; Shimojo S; Koori T; Mora M; Riggs JE; Oh SJ; Koga Y; Sue CM; Yamamoto A; Murakami N; Shanske S; Byrne E; Bonilla E; Nonaka I; DiMauro S; Hirano M
Nature; 2000 Aug; 406(6798):906-10. PubMed ID: 10972294
[TBL] [Abstract][Full Text] [Related]
4. Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene.
Sugie K; Yoshizawa H; Onoue K; Nakanishi Y; Eura N; Ogawa M; Nakano T; Sakaguchi Y; Hayashi YK; Kishimoto T; Shima M; Saito Y; Nishino I; Ueno S
Neuropathology; 2016 Dec; 36(6):561-565. PubMed ID: 27145725
[TBL] [Abstract][Full Text] [Related]
5. Infantile autophagic vacuolar myopathy is distinct from Danon disease.
Yamamoto A; Morisawa Y; Verloes A; Murakami N; Hirano M; Nonaka I; Nishino I
Neurology; 2001 Sep; 57(5):903-5. PubMed ID: 11552028
[TBL] [Abstract][Full Text] [Related]
6. Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease).
Takahashi M; Yamamoto A; Takano K; Sudo A; Wada T; Goto Y; Nishino I; Saitoh S
Ann Neurol; 2002 Jul; 52(1):122-5. PubMed ID: 12112061
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease.
Horváth J; Ketelsen UP; Geibel-Zehender A; Boehm N; Olbrich H; Korinthenberg R; Omran H
Neuropediatrics; 2003 Jun; 34(5):270-3. PubMed ID: 14598234
[TBL] [Abstract][Full Text] [Related]
8. Danon's disease (X-linked vacuolar cardiomyopathy and myopathy): a case with a novel Lamp-2 gene mutation.
Lacoste-Collin L; Garcia V; Uro-Coste E; Arné-Bes MC; Durand D; Levade T; Delisle MB
Neuromuscul Disord; 2002 Nov; 12(9):882-5. PubMed ID: 12398843
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice.
Tanaka Y; Guhde G; Suter A; Eskelinen EL; Hartmann D; Lüllmann-Rauch R; Janssen PM; Blanz J; von Figura K; Saftig P
Nature; 2000 Aug; 406(6798):902-6. PubMed ID: 10972293
[TBL] [Abstract][Full Text] [Related]
10. A Nationwide Survey on Danon Disease in Japan.
Sugie K; Komaki H; Eura N; Shiota T; Onoue K; Tsukaguchi H; Minami N; Ogawa M; Kiriyama T; Kataoka H; Saito Y; Nonaka I; Nishino I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30413001
[TBL] [Abstract][Full Text] [Related]
11. [Danon disease].
Nishino I
Ryoikibetsu Shokogun Shirizu; 2001; (36):225-9. PubMed ID: 11596375
[No Abstract] [Full Text] [Related]
12. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease).
Lobrinus JA; Schorderet DF; Payot M; Jeanrenaud X; Bottani A; Superti-Furga A; Schlaepfer J; Fromer M; Jeannet PY
Neuromuscul Disord; 2005 Apr; 15(4):293-8. PubMed ID: 15792868
[TBL] [Abstract][Full Text] [Related]
13. Danon disease as a cause of autophagic vacuolar myopathy.
Yang Z; Vatta M
Congenit Heart Dis; 2007; 2(6):404-9. PubMed ID: 18377432
[TBL] [Abstract][Full Text] [Related]
14. Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation.
Cottinet SL; Bergemer-Fouquet AM; Toutain A; Sabourdy F; Maakaroun-Vermesse Z; Levade T; Chantepie A; Labarthe F
J Inherit Metab Dis; 2011 Apr; 34(2):515-22. PubMed ID: 21161685
[TBL] [Abstract][Full Text] [Related]
15. Mild form of Danon disease: two case reports.
Yasui T; Nagaoka U; Oya Y; Uruha A; Karashima J; Funai A; Miyamoto K; Matsubara S; Sugaya K; Takahashi K; Inoue M; Okubo M; Sugie K; Nishino I
Neuromuscul Disord; 2021 Nov; 31(11):1207-1211. PubMed ID: 34702653
[TBL] [Abstract][Full Text] [Related]
16. LAMP-2 deficiency (Danon disease).
Di Mauro S; Tanji K; Hirano M
Acta Myol; 2007 Jul; 26(1):79-82. PubMed ID: 17915578
[No Abstract] [Full Text] [Related]
17. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease.
Kim H; Cho A; Lim BC; Kim MJ; Kim KJ; Nishino I; Hwang YS; Chae JH
Muscle Nerve; 2010 Jun; 41(6):879-82. PubMed ID: 20513107
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Danon disease in a male patient and his affected mother.
Sugie K; Koori T; Yamamoto A; Ogawa M; Hirano M; Inoue K; Nonaka I; Nishino I
Neuromuscul Disord; 2003 Nov; 13(9):708-11. PubMed ID: 14561493
[TBL] [Abstract][Full Text] [Related]
19. Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease.
Echaniz-Laguna A; Mohr M; Epailly E; Nishino I; Charron P; Richard P; Guiraud-Chaumeil C; Tranchant C
Muscle Nerve; 2006 Mar; 33(3):393-7. PubMed ID: 16372318
[TBL] [Abstract][Full Text] [Related]
20. Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation.
Bui YK; Renella P; Martinez-Agosto JA; Verity A; Madikians A; Alejos JC
Pediatr Transplant; 2008 Mar; 12(2):246-50. PubMed ID: 18282207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
